Penserra Capital Management LLC Allogene Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$3.17 - $5.96 $22,535 - $42,369	7,109 Added 33.57%	28,284 $89,000
Q2 2023 Aug 11, 2023	BUY	$4.53 - $6.74 $13,884 - $20,658	3,065 Added 16.92%	21,175 $105,000
Q1 2023 Apr 24, 2023	BUY	$4.92 - $8.21 $24,058 - $40,146	4,890 Added 36.99%	18,110 $89,000
Q4 2022 Feb 13, 2023	SELL	$5.62 - $11.11 $22,772 - $45,017	-4,052 Reduced 23.46%	13,220 $83,000
Q3 2022 Nov 14, 2022	BUY	$10.32 - $17.28 $121,074 - $202,728	11,732 Added 211.77%	17,272 $186,000
Q2 2022 Aug 15, 2022	SELL	$6.78 - $12.28 $11,770 - $21,318	-1,736 Reduced 23.86%	5,540 $63,000
Q1 2022 May 13, 2022	BUY	$7.65 - $15.29 $55,661 - $111,250	7,276 New	7,276 $66,000
Q4 2021 Feb 15, 2022	SELL	$13.13 - $24.52 $42,738 - $79,812	-3,255 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$21.01 - $27.64 $735 - $967	35 Added 1.09%	3,255 $83,000
Q2 2021 Aug 12, 2021	BUY	$23.49 - $35.8 $939 - $1,432	40 Added 1.26%	3,220 $83,000
Q1 2021 May 13, 2021	SELL	$25.79 - $39.02 $1,547 - $2,341	-60 Reduced 1.85%	3,180 $112,000
Q4 2020 Feb 12, 2021	BUY	$25.24 - $43.45 $51,792 - $89,159	2,052 Added 172.73%	3,240 $81,000
Q3 2020 Nov 13, 2020	BUY	$32.38 - $44.96 $38,467 - $53,412	1,188 New	1,188 $44,000

162

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.